Understanding Brain Changes in Cocaine Addiction
Elucidating Ih Biophysical Epigenetic Modifications in VTA Dopaminergic Neurons after Contingent and Non-Contingent Cocaine Administration
This research explores how cocaine changes specific brain cells to better understand why addiction happens.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Puerto Rico Med Sciences NIH-funded |
| Lab location | 1 site (San Juan, United States) |
| Project ID | NIH-11371804 on NIH RePORTER |
What this research studies
Our brains have a special area called the VTA that handles reward and reinforcement, which is affected by drugs like cocaine. Inside the VTA, certain brain cells have an electrical current, called Ih, that plays a big role in how these cells work. Cocaine exposure can change this Ih current, and we believe these changes might be a key reason why addiction develops. This project looks at how these changes are controlled by 'epigenetic' mechanisms, which are like switches that turn genes on or off, to see how they contribute to cocaine addiction.
Who could benefit from this research
Good fit: This foundational research is for future patients struggling with cocaine addiction, as it aims to uncover new biological targets for treatment.
Not a fit: Current patients will not receive direct benefit from this basic science research, as it does not involve patient participation or new treatments at this stage.
Why it matters
Potential benefit: If successful, this work could lead to new ways to treat cocaine addiction by targeting the specific brain changes that make it so hard to quit.
How similar studies have performed: Previous work has shown that cocaine exposure alters the Ih current in the brain, suggesting this approach builds on existing knowledge while exploring new epigenetic mechanisms.
Where this research is happening
San Juan, United States
- University of Puerto Rico Med Sciences — San Juan, United States (Active)
Researchers
- Principal investigator: Jimenez-Rivera, Carlos a — University of Puerto Rico Med Sciences
- Study coordinator: Jimenez-Rivera, Carlos a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.